In detail, when somatic MLH1 hypermethylation and/or a BRAF mutation are identified in CRC, or only MLH1 hypermethylation is identified in EC, patients are excluded from the LS germinal test, as reported by Tibiletti et al. [5]. This evidence concerns the gene MLH1 and colorectal carcinoma.